Literature DB >> 8733949

A nonparametric subject-specific population method for deconvolution: II. External validation.

K E Fattinger1, D Verotta.   

Abstract

A lot of attention has been given in the past to deconvolution and in particular to its nonparametric variants. In a companion paper (1), we present a fully nonparametric deconvolution method in which subject specificity is explicitly taken into account. To do so we use so-called "longitudinal splines." A longitudinal spline is a nonparametric function composed of a template spline, in common to all subjects, and of a distortion spline representing the difference of the subject's function from the template. In this paper we concentrate on testing and documenting the performance of this nonparametric methodology in terms of the approximation of unknown functions. We simulate population data using parametric functions, and use longitudinal splines to recover the unknown functions. We consider different estimation methods including (1) parametric nonlinear mixed effect, (2) least squares, and (3) two-stage. Methods 2-3 are more robust than Method 1, and obtain reliable estimates of the unknown functions. The lack of robustness of Method 1 appears to be due to the misspecifications of the distribution of the subjects' parameters. Results also suggest that in a data-rich situation nonparametric nonlinear mixed-effect models should be preferred.

Mesh:

Year:  1995        PMID: 8733949     DOI: 10.1007/bf02353464

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  5 in total

1.  Non-linear models for the analysis of longitudinal data.

Authors:  E F Vonesh
Journal:  Stat Med       Date:  1992 Oct-Nov       Impact factor: 2.373

2.  Comments on two recent deconvolution methods.

Authors:  D Verotta
Journal:  J Pharmacokinet Biopharm       Date:  1990-10

3.  A nonparametric subject-specific population method for deconvolution: I. Description, internal validation, and real data examples.

Authors:  K E Fattinger; D Verotta
Journal:  J Pharmacokinet Biopharm       Date:  1995-12

4.  A new method to explore the distribution of interindividual random effects in non-linear mixed effects models.

Authors:  K E Fattinger; L B Sheiner; D Verotta
Journal:  Biometrics       Date:  1995-12       Impact factor: 2.571

5.  Population pharmacokinetic data and parameter estimation based on their first two statistical moments.

Authors:  S L Beal
Journal:  Drug Metab Rev       Date:  1984       Impact factor: 4.518

  5 in total
  8 in total

1.  Use of a pharmacokinetic/pharmacodynamic model to design an optimal dose input profile.

Authors:  K Park; D Verotta; S K Gupta; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1998-08

2.  Modeling nicotine arterial-venous differences to predict arterial concentrations and input based on venous measurements: application to smokeless tobacco and nicotine gum.

Authors:  Maria Pitsiu; Jean-Michel Gries; Neal Benowitz; Steven G Gourlay; Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-08       Impact factor: 2.745

Review 3.  Biomarkers, validation and pharmacokinetic-pharmacodynamic modelling.

Authors:  Wayne A Colburn; Jean W Lee
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

4.  SPLINDID: a semi-parametric, model-based method for obtaining transcription rates and gene regulation parameters from genomic and proteomic expression profiles.

Authors:  Kavitha Bhasi; Alan Forrest; Murali Ramanathan
Journal:  Bioinformatics       Date:  2005-08-11       Impact factor: 6.937

5.  Assumption testing in population pharmacokinetic models: illustrated with an analysis of moxonidine data from congestive heart failure patients.

Authors:  M O Karlsson; E N Jonsson; C G Wiltse; J R Wade
Journal:  J Pharmacokinet Biopharm       Date:  1998-04

6.  A nonparametric subject-specific population method for deconvolution: I. Description, internal validation, and real data examples.

Authors:  K E Fattinger; D Verotta
Journal:  J Pharmacokinet Biopharm       Date:  1995-12

7.  A semiparametric method for describing noisy population pharmacokinetic data.

Authors:  K Park; D Verotta; T F Blaschke; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1997-10

8.  Oral heroin in opioid-dependent patients: pharmacokinetic comparison of immediate and extended release tablets.

Authors:  Ludwig Perger; Katharina M Rentsch; Gerd A Kullak-Ublick; Davide Verotta; Karin Fattinger
Journal:  Eur J Pharm Sci       Date:  2008-11-25       Impact factor: 4.384

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.